Wanbury Begins Commercial Production of Anesthetic API in Tanku, India Unit; Shares Up 8%

MT Newswires Live

Jan 28

Pharmaceutical company Wanbury (NSE:WANBURY, BOM:524212) has begun commercial production for a high-potency anesthetic active pharmaceutical ingredients (API) at the company's Tanku facility in Andhra Pradesh, India, according to a Wednesday filing to the Indian bourses.

The API is expected to generate incremental revenue of around 180 million Indian rupees in the fiscal fourth quarter of the financial year 2025-26.

The company has launched four new anesthetic APIs at its Tanuku manufacturing facility, and targets about 1 billion rupees incremental revenue from this and four new high-value APIs by the financial year 2026-27.

The company's shares were up over 8% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606795430"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606795430\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606795430?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 16:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606795430","market":"sh","top_or_hot":-1,"title":"Wanbury Begins Commercial Production of Anesthetic API in Tanku, India Unit; Shares Up 8%","media":"MT Newswires Live","content":"<html><body><p> Pharmaceutical company Wanbury (NSE:WANBURY, BOM:524212) has begun commercial production for a high-potency anesthetic active pharmaceutical ingredients (API) at the company's Tanku facility in Andhra Pradesh, India, according to a Wednesday filing to the Indian bourses.</p><p>The API is expected to generate incremental revenue of around 180 million Indian rupees in the fiscal fourth quarter of the financial year 2025-26.</p><p>The company has launched four new anesthetic APIs at its Tanuku manufacturing facility, and targets about 1 billion rupees incremental revenue from this and four new high-value APIs by the financial year 2026-27.</p><p>The company's shares were up over 8% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wanbury Begins Commercial Production of Anesthetic API in Tanku, India Unit; Shares Up 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWanbury Begins Commercial Production of Anesthetic API in Tanku, India Unit; Shares Up 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-28 16:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Pharmaceutical company Wanbury (NSE:WANBURY, BOM:524212) has begun commercial production for a high-potency anesthetic active pharmaceutical ingredients (API) at the company's Tanku facility in Andhra Pradesh, India, according to a Wednesday filing to the Indian bourses.</p><p>The API is expected to generate incremental revenue of around 180 million Indian rupees in the fiscal fourth quarter of the financial year 2025-26.</p><p>The company has launched four new anesthetic APIs at its Tanuku manufacturing facility, and targets about 1 billion rupees incremental revenue from this and four new high-value APIs by the financial year 2026-27.</p><p>The company's shares were up over 8% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7103","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2606795430","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606795430","pubTimestamp":1769588796,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pharmaceutical company Wanbury  has begun commercial production for a high-potency anesthetic active pharmaceutical ingredients  at the company's Tanku facility in Andhra Pradesh, India, according to a Wednesday filing to the Indian bourses.The API is expected to generate incremental revenue of around 180 million Indian rupees in the fiscal fourth quarter of the financial year 2025-26.The company has launched four new anesthetic APIs at its Tanuku manufacturing facility, and targets about 1 billion rupees incremental revenue from this and four new high-value APIs by the financial year 2026-27.The company's shares were up over 8% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7103":"保健护理产品经销商","BK6100":"保健护理服务","BK4023":"应用软件","API":"声网","BK4535":"淡马锡持仓","OTX.SI":"迈怡汇有限公司","BK4503":"景林资产持仓","BK6520":"工商业服务概念","API.AU":"Australian Pharma Industries","BK4551":"寇图资本持仓"},"translate_title":"Wanbury开始在印度坦库工厂商业化生产麻醉原料药；股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"API":1,"MNDmain":1.5,"OTX.SI":1.5,"API.AU":1},"content_text":"Pharmaceutical company Wanbury (NSE:WANBURY, BOM:524212) has begun commercial production for a high-potency anesthetic active pharmaceutical ingredients (API) at the company's Tanku facility in Andhra Pradesh, India, according to a Wednesday filing to the Indian bourses.The API is expected to generate incremental revenue of around 180 million Indian rupees in the fiscal fourth quarter of the financial year 2025-26.The company has launched four new anesthetic APIs at its Tanuku manufacturing facility, and targets about 1 billion rupees incremental revenue from this and four new high-value APIs by the financial year 2026-27.The company's shares were up over 8% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}